Abstract
Mesenchymal stem cell (MSC)-based tissue engineering strategies are of interest in the field of bone tissue regenerative medicine. MSCs are commonly investigated in combination with growth factors (GFs) and biomaterials to provide a regenerative environment for the cells. However, optimizing how biomaterials interact with MSCs and efficiently deliver GFs, remains a challenge. Here, via plasma polymerization, tissue culture plates are coated with a layer of poly (ethyl acrylate) (PEA), which is able to spontaneously permit fibronectin (FN) to form fibrillar nanonetworks. However, vitronectin (VN), another important extracellular matrix (ECM) protein forms multimeric globules on the polymer, thus not displaying functional groups to cells. Interestingly, when FN and VN are co-absorbed onto PEA surfaces, VN can be entrapped within the FN fibrillar nanonetwork in the monomeric form providing a heterogeneous, open ECM network. The combination of FN and VN promote MSC adhesion and leads to enhanced GF binding; here we demonstrate this with bone morphogenetic protein-2 (BMP2). Moreover, MSC differentiation into osteoblasts is enhanced, with elevated expression of osteopontin (OPN) and osteocalcin (OCN) quantified by immunostaining, and increased mineralization observed by von Kossa staining. Osteogenic intracellular signalling is also induced, with increased activity in the SMAD pathway. The study emphasizes the need of recapitulating the complexity of native ECM to achieve optimal cell-material interactions.
Keywords: Mesenchymal stem cells, Polymer organized extracellular matrix, Vitronectin, Fibronectin, Bone morphogenetic protein-2, Osteogenesis
Graphical abstract
Highlights
-
•
Vitronectin can be incorporated within fibronectin fibril networks upon co-coating onto poly (ethyl acrylate) modified surfaces.
-
•
Fibronectin and vitronectin networks promote mesenchymal stem cell adhesion and induce α5 integrin clustering.
-
•
Fibronectin and vitronectin nanonetworks improve bone morphogenetic protein-2 presentation to mesenchymal stem cells and thus facilitates osteogenesis.
CRediT author statement
Yinbo Xiao: Methodology, Formal analysis, Investigation, Writing – Original Draft; Hannah Donnelly: Data Curation, Writing – Review & Editing, Supervision; Mark Sprott: Visualization, Investigation; Jiajun Luo: Visualization; Vineetha Jayawarna: Data Curation, Visualization; Leandro Lemgruber: Visualization; P. Monica Tsimbouri: Methodology; Robert M.D. Meek: Resources; Manuel Salmeron-Sanchez: Resources, Supervision; Matthew J. Dalby: Conceptualization, Writing – Review & Editing, Supervision, Funding acquisition.
1. Introduction
Biomaterials in bone tissue engineering have gained popularity as a way to aid bone regeneration in response to disease, trauma, or injury. Growing biomaterials are developed to enhance initial stem cells’ adhesion, and subsequently, drive their differentiation into osteoblasts, thus promoting bone regeneration [1]. However, often for cells to adhere effectively to these materials they must first organise extracellular matrix (ECM) proteins absorbed onto the material surface. The presentation of ECM ligands ultimately affects how cells sense such microenvironmental stimuli through revealing cryptic sites that cells can adhere to or that growth factors can absorb onto [2]. Further to this, these material-based approaches do not typically control growth factor (GF) presentation or GF-ECM binding [3]. This commonly means that where GFs are required, such as in bone morphogenetic protein 2 (BMP-2) in bone regeneration, uncontrolled, soluble delivery of GFs at supraphysiological levels is employed [4]. Therefore, the development of materials that exploit ECM proteins to reveal cell adhesion and GF binding sites, that can be decorated with low, but effective loads of GFs may provide a better approach for controlling stem cell differentiation and improving the translation of these systems to the clinic.
ECM proteins play a pivotal role in modulating many cellular processes, such as adhesion, migration and differentiation [2]. Once attached, cell membrane receptors such as integrins, can recognise and couple to the cell-binding domains of ECM proteins [5]. Such integrin-ECM couplings can transduce extracellular ECM signals via the actin cytoskeleton, regulating related gene transcriptional activities and thus directing cell behaviours [5]. ECM proteins containing heparin-II binding sites have been shown to bind several families of GFs with high affinity [6]. As such, the complex ECM network serves as a GF reservoir, releasing GFs in a sustained manner to the local microenvironment and thus orchestrating cell biological processes [6,7]. It should be noted that the availability of these critical functional domains depends on the ECM protein conformation. Folded or globular protein conformations can hide these functional domains rendering them unavailable for interaction, limiting their biological actions and utilization for tissue bioengineering [8,9].
Polymers are currently being investigated as a versatile and potent tool in the field of tissue engineering. Certain polymers allow precise control of the physical and chemical properties of the materials, such as mechanical properties, topographical features and chemical composition [9]. By optimizing surface chemical modification, our previous work has shown that poly (ethyl acrylate) (PEA) could spontaneously drive fibronectin (FN) into fibrillar-like networks, which physiologically mimics their in vivo conformation [10,11]. This fibrillar conformation can expose the key functional domains of FN, e.g. heparin-II GF binding domain and the RGD (Arginine-Glycine-Aspartate) integrin-binding domain, subsequently allowing control of GF delivery and cellular adhesion, and ultimately cellular differentiation [11]. Importantly, ultra-low doses of GFs such as bone morphogenetic protein-2 (BMP2), and vascular endothelial growth factor (VEGF), have previously been shown to successfully bind to the FN fibrillar network and elicit cell-type-specific responses [[12], [13], [14]]. As such, PEA has been successfully translated to in vivo studies and veterinary trials on large bone defects with promise for both osteogenic and angiogenic outcomes [[12], [13], [14]].
Besides FN, vitronectin (VN) is another critical component within the ECM network, serving the function of being a biological ECM glue [15]. In contrast to the structural functions of other ECM proteins, VN serves as a matricellular protein, whose functions are achieved by binding to other matrix proteins and thus form an interconnected ECM network [16]. Its biological functions are dependent on the conformation of its secondary structure. Upon undergoing a conformational change from monomeric form to multimeric form, VN becomes more biologically active by exposing its heparin-binding and cell-binding sites [[17], [18], [19]]. In particular, the cellular αV integrins are shown to couple with cell-binding sites of VN [20]. Interestingly, unlike FN-binding α5 integrins, αV integrins are mostly shown to confine to the cell edge and exhibit a weaker bond force to ECM [21,22]. It is of note that cells are not able to drive FN fibrillogenesis in the absence of VN-αV integrin coupling [22]. These findings suggest that the synergistic control among integrin-ECM coupling affects cell behaviours and ECM remodelling. Our previous work has already shown that VN activity is dependent on the surface chemical composition [23,24]. By changing the amount of hydroxyl groups to increase surface hydrophobicity, the bioactivity of VN was increased, leading to increased cell spreading and focal adhesion development in cells [25]. Moreover, coinciding with the previous study, the presence of VN can increase FN assembly and enhance cell-mediated FN reorganization and secretion [23,24].
Previous studies have demonstrated that PEA can spontaneously drive absorbed FN into biological nanonetworks [13,14]. Further, when VN is mixed with FN, nanonetworks are also seen and enhance cell adhesion [[22], [23], [24]]. However, these studies don't clarify the ability of these blended FN/VN networks to interact with GFs, such as BMP-2, and to direct MSC fates. In this new study, by adding BMP2 into such a blended ECM network, we demonstrate that the FN + VN ECM network can bind increased levels of BMP-2 and effectively present it to MSCs, thus directing osteogenesis. Based on the plasma polymerization of PEA [26], we explore the effects of FN and VN on α5/αV integrin ligation. As has been shown before [23], VN was observed to be within PEA-driven FN fibril networks and the presence of VN promoted cell spreading and adhesion. Then the GF BMP2, widely used in bone tissue engineering [27,28], was incorporated into these ECM networks and the osteogenesis of MSCs was evaluated. We found this complex ECM composite could bind increased levels of BMP2 and effectively present it to MSCs, thus directing robust osteogenesis. These findings shed light on the important role of ECM complexity in vitro.
2. Materials and methods
2.1. Plasma polymerization
Plasma equipment was set up according to our previous work (Fig. 1A) [13,26]. A custom-built plasma reactor was used to polymerise ethyl acrylate (EA) via plasma polymerization. The EA plasma was generated by two capacitively coupled copper band electrodes which connected to a radio frequency power supply. Details of other design and operation considerations to facilitate the polymerization of EA can be found in our previous study [13,26]. The chemical structure of PEA was shown in Fig. 1B. Briefly, samples (Glass coverslips, Nunc™ Thermanox™ coverslips or Commercial Corning® 48-well tissue culture plates (TCP)) were placed in the plasma chamber vertically to the plasma flow. Then, samples were exposed to air plasma for 5 min at 50 W of radio frequency (RF) incident power to ensure the removal of any residual organic matter. As for the PEA plasma, the RF power applied to the plasma chamber was set as 50 W, and the plasma treatment time was set as 15 min. Before the ECM coating for cell culture, the samples were sterilized under ultraviolet (UV) light for 30 min.
2.2. Water contact angle (WCA) measurement
Water contact angle (WCA) measurements were taken on PEA-coated glass coverslips pre and post-UV treatment. Static contact angles (SCAs) were measured by dropping a 3 μL drop of deionised water onto the surfaces using a Theta optical tensiometer (Biolin Scientific, Stockholm, Sweden) (n = 12).
2.3. X-ray photoelectron spectra (XPS) analysis
After plasma polymerization, samples were sent out to the National EPSRC Users’ Service (NEXUS) (found at: http://www.ncl.ac.uk/nexus/) for X-ray photoelectron spectra (XPS) analysis. A K-alpha XPS system (ThermoScientific) equipped with a monochromatic Al K-alpha source was used to analyse each sample three times at a maximum beam size of 400 μm × 800 μm. Parameters were set up as follows: X-ray energy: 1486.68 eV; voltage: 12 kV; current: 3 mA; power: 36 W. Spectra analysis and curve fitting were performed using CasaXPS software.
2.4. ECM and BMP2 adsorption
For ECM protein adsorption, phosphate-buffered saline (PBS) solution containing human FN (20 μg ml−1) (Sigma-Aldrich, #F2006), human VN (20 μg ml−1) (Sigma-Aldrich, #5051), or the blend of FN (10 μg ml−1) and VN (10 μg ml−1) were coated onto PEA modified TCPs for 1 h at room temperature, termed as FN, VN and FN + VN respectively. Following PBS washes, samples were ready for cell culture. For GF adsorption, BMP2 (Sigma-Aldrich, #H4791) was diluted with PBS (final concentration 50 ng ml−1) and incubated onto ECM-coated TCPs for 2 h at room temperature, followed by washing with PBS. TCPs without plasma PEA treatment were used as the control substrate.
2.5. Atomic Force Microscopy (AFM)
ECM protein conformation images were obtained using Atomic Force Microscopy (AFM). Before ECM protein absorption, PEA-treated glass coverslips were imaged by AFM as the control. After ECM protein absorption, substrates were washed with PBS, and then finally with deionised water. The samples were then dried with nitrogen gas and allowed for further air-drying before AFM imaging. The JPK Nanowizard 4 was used for imaging and the JPK Data Processing software version 5 was used for image analysis. A pyramidal silicon tip was utilised for alternating contact mode imaging, with a resonance frequency of 70 kHz and stiffness of 3 N m−1.
For the surface roughness analysis, the 0.5 × 0.5 μm2 image (1 Hz) was used to analyse the surface roughness of any given condition. The Peak-to-Valley roughness was calculated using the JPK DP software after image levelling to remove variations or tilts in the background.
The estimation of the coating thickness was performed according to our previous work [26]. Briefly, a thin scratch was manually applied with a sharp blade into the coating, to expose the underlying glass substrate. The surface was then viewed under a microscope to identify the scratch, and the area across the cut was scanned by AFM. The thickness of the polymer coating was estimated by profilometry at the boundary of the scratched and unscratched area, n = 6 (minimum).
2.6. BMP2 enzyme-linked immunosorbent assay (ELISA)
After ECM absorption and subsequent GF absorption, the GF supernatant from each substrate was collected. The concentration of BMP2 in the stock solution and supernatant from each substrate was determined by the BMP2 Enzyme-linked immunosorbent assay (ELISA) kit (R&D System, #DY355-05) according to the manufacturer's protocol. In general, high-binding plates were coated by the capture antibody overnight. Then, blocking buffer, samples (both test samples and standard samples) and detection antibodies were subsequently added to the plate one by one and between each step, the plates were washed with 0.05% (v/v) Tween-20/PBS for 5 × 5 min. After that, substrate solution was added and incubated for 20 min and then stop solution was added to stop the reaction. The ELISA plate was read using a plate reader at the wavelength of 450 nm and 570 nm. The absorbed BMP2 mass density was calculated by the following equation.
Equation 1 The equation for absorbed BMP2 density calculation.
ΔConcentration: The subtraction between the BMP2 concentration of the stock solution and the BMP2 concentration of the collected supernatant.
2.7. P5F3 ELISA
P5F3 antibody was utilised to measure the availability of heparin II binding domains of FN [14]. After ECM absorption, samples were blocked with 1% bovine serum albumin (BSA)/PBS for 30 min at room temperature. Then, samples were incubated with primary antibody against the P5F3 domain (FN Heparin-binding domain, Santa Cruz Biotechnology, #sc-18827, 1:2000) for 1 h, followed by incubation with secondary antibody (goat-anti-mouse-HRP, ThermoFisher Scientific, #62–6520, 1:10,000) for 1 h. After that, the substrate solution (R&D System, #DY999) was added and incubated for 20 min. The reaction was stopped by adding the stop solution (R&D System, #DY994), and the ELISA plate was read using a plate reader at the wavelength of 450 nm.
2.8. Primary cell isolation and cell culture
Human MSCs were isolated from the bone marrow aspirates of patients undergoing joint replacement surgery. The permission to use the residual tissues was given by the Greater Glasgow and Clyde NHS Biorepository. Primary MSCs were maintained by Dulbecco's Modified Eagle Medium (DMEM, Sigma-Aldrich) supplemented with 10% Fetal Bovine Serum (FBS, Sigma-Aldrich), 1% sodium pyruvate (11 mg ml−1, Sigma-Aldrich), 1% Gibco non-essential amino acids (NEAA, ThermoFisher Scientific) and 2% antibiotics (6.74 U mL−1 penicillin-streptomycin and 0.2 μg ml−1 fungizone, Sigma-Aldrich). For experiments, MSCs (3000 cells cm−2) at the 2nd – 4th passage were seeded onto the materials, and the medium was changed twice a week. The experiments were repeated 3 times with MSCs from 3 patient donors. For the osteogenesis medium in the positive control group, the DMEM basal media was supplied with 100 nM Dexamethasone, 200 μM Ascorbic acid, and 10 mM β-glycerophosphate.
2.9. In-cell western (ICW)
After cell culture, the samples were fixed with 4% formaldehyde for 15 min at 37 °C and then permeabilised with 0.5% Triton-X/PBS, followed by blocking with 1% BSA/PBS for 1.5 h at room temperature. Samples were then incubated with primary antibody (pSMAD, #13820S, Cell Signalling Technology, 1:400) and then secondary antibody IRDye 800CW (LI-COR, #926–32211, 1:800) and CellTag 700 Stain (LI-COR, #926–41090, 1:500). After each incubation, samples were washed with 0.1% Tween-20/PBS 3 times for 5 min. The plates were dried in a fume hood, and then infrared signal readings were taken using an Odyssey infrared imaging system. Analysis was carried out by normalising the fluorescence units associated with the abundance of the protein of interest to the fluorescence units (in 800 nm channel) associated with the CellTag fluorescence units (in 700 nm channel).
2.10. Immunostaining
After cell culture, the samples were fixed with 4% formaldehyde for 15 min at 37 °C and then permeabilised by treating with 0.5% Triton-X/PBS, followed by blocking with 1% BSA/PBS for 5 min at 4 °C. Samples were incubated with primary antibody overnight at 4 °C (Phalloidin, #A12379, ThermoFisher Scientific, 1:200; Vinculin, #V9264, Sigma-Aldrich, 1:400; OPN, #sc-21742, Santa Cruz Biotechnology, 1:50; OCN, #sc-73464, Santa Cruz Biotechnology, 1:50) and then secondary antibody Texas red conjugated Goat anti-mouse secondary antibody for 1 h at room temperature. After each incubation, samples were washed with 0.1% Tween-20/PBS 3 times for 5 min. Samples were mounted using the mounting medium containing 4’, 6-diamidino-2- phenylindole (DAPI), before imaging in fluorescence microscopy. The images are acquired by EVOS M700 microscope (ThermoFisher Scientific). Images were processed and the integrated densities were determined by ImageJ.
Vinculin images were used for focal adhesion (FA) analysis according to the description by Horzum et al. [29]. Images were analyzed with a threshold area of 0.5 μm2 and 0–0.99 circularity. The binarized images of the FAs were measured and several parameters were used for FA analysis, including FA number per cell, the FA length and FA area.
2.11. Super-resolution microscopy
After the aforementioned immunostaining procedures, samples were ready for super-resolution microscopy. Structured Illumination microscopy (SR-SIM) was performed using a Zeiss Elyra PS.1 super-resolution microscope (Carl Zeiss, Germany). A plan-Apochromat 63x/1.4 Oil lens was used, and Z-steps of 0.2 μm were acquired (total thickness between 5 and 7 μm) in five rotations using the ZEN Black Edition Imaging software.
2.12. Von Kossa staining
After 28 days of culture, the samples were fixed with 4% formaldehyde for 15 min at 37 °C. Then 5% silver nitrate solution was added to the samples and the samples were kept under UV light for 30 min. After washing in deionised water, the samples were incubated with 5% sodium thiosulphate for 10 min at room temperature. After re-washing in deionised water, the samples were incubated by nuclear fast red for 10 min. The samples were washed with deionised water and washed with 70% ethanol for the final wash. After drying in the fume hood overnight, samples were ready for image acquisition. Light microscopy images were obtained using the EVOS M700 microscope (ThermoFisher Scientific). Integrated density measurements were obtained by using the LiCor Odyssey Sa system in the brightness setting.
2.13. Statistical analysis
Data were presented as means ± standard deviation or means ± standard error of the mean. Kruskal-Wallis test or Ordinary two-way ANOVA with Tukey's test was applied for multi-group comparison were applied for statistic analysis using GraphPad Prism 8TM software. The methods were stated as per figure legends.
3. Results
3.1. Chemical characterization of PEA substrates
XPS analysis was carried out to determine the chemical composition and binding confirmation of the top 10 nm of the plasma polymerised substrates. The chemical structure of PEA was shown in Fig. 1B. In general, after plasma treatment, the chemical signature of PEA was confirmed on both glass and Thermanox tissue culture plastic coverslips (Fig. 2A and B). This was identified via reference to the literature [30] and previous PEA-related surface modification studies [14,31], as the PEA peaks were identical to those found in other plasma PEA studies [13,26]. The relative positions relating to the chemical motif of PEA could be identified; mainly the presence of a large peak corresponding to C–C bonds found at 284.9 eV (C1) as a reference and the peaks at 285.1 eV (C2), 286.2 eV (C3), 288.5 eV (C4) which correspond to the C–C–C bonds, C–O bonds, and C O bonds respectively (Fig. 2A and B). As previously noted, the binding ratios between these 3 main peaks are slightly altered from pure PEA, due to plasma-induced monomer fragmentation [13,26], as plasma polymerization leads to a partial loss of functional groups and crosslinking. In the oxygen spectra, the peaks corresponding to the C O and C–O–C bonds were found at 531.5 eV (O1) and 533.2 eV (O2) respectively (Fig. 2A and B). Several peaks were observed between 288 and 296 eV on untreated Thermanox coverslips within the carbon spectra which may correspond to the C C bond in aromatic rings, whereas these carbon binding peaks, as well as nitrogen peaks in wide spectra, were not observed on scans after PEA treatment demonstrating successful coating (Fig. S1A, Supporting Information). Additionally, the non-treated glass coverslips possess relatively high percentages of silicon, as calculated from the wide scan (Fig. S1B, Supporting Information). However, post plasma polymerization, there was no silicon detected on the PEA-treated substrates, which only presented the elements carbon and oxygen on its surface. These results show that plasma polymerization can adequately cover the surfaces of both Thermanox and glass coverslips in PEA, with a thickness of 166 ± 18 nm (measured by AFM scratch test).
To sterilize and disinfect the biomaterials for biological application, UV irradiation is commonly utilised [32]. However, this can affect the surface chemical composition and thus limit their in vitro and in vivo use [32]. Thus, the static WCA measurement was carried out to determine if the PEA-treated coverslips were significantly altered by UV exposure. The WCA of PEA-treated coverslips before and after UV exposure were 77.12° ± 4.30 and 75.78° ± 4.11 respectively, with no statistical difference (Fig. S2, Supporting Information). This indicates that the UV treatment does not alter the PEA coating and that the sterilized coverslips can be further used for cell culture.
3.2. ECM conformation on PEA substrate
AFM was performed to determine the nanostructures formed by the absorbed proteins on the PEA surfaces. Plasma polymerised PEA surfaces without ECM coating were observed by AFM to be flat enough to allow visualisation in protein conformational studies as the low RMS roughness is unlikely to mask or hide any protein-related structures (Fig. S3, Supporting Information) [31]. It was seen that PEA coatings were able to drive fibrillogenesis of absorbed FN into fibrillar nanonetworks (Fig. 3A–i; Figs. S4–i, Supporting Information), resembling the fibrillar in-vivo FN organization [13,14]. In contrast, VN alone formed large, globular, aggregations of between 20 nm and 50 nm in height when absorbed onto PEA (Fig. 3A–iii; Fig. S4-iii, Supporting Information). The size of one single VN molecular is around 3–11 nm [24], suggesting the aggregates detected are multimers of VN molecules. When proteins (FN + VN) were co-adsorbed, the large globular conformation of VN was not present on PEA surfaces, and, instead, FN nanonetworks were observed to present additional peaks which can be attributed to VN (Fig. 3A–ii (blue star); Fig. S4-ii, Supporting Information), as they were not present on PEA + FN scans alone. Further, peak-to-valley roughness on the PEA + FN + VN surface was measured to significantly decrease compared to the PEA + VN surface, with PEA + FN + VN instead presenting peaks within the range of a single VN molecule (Fig. 3B). The VN was observed within the FN fibrillar structure, allowing us to postulate that VN could likely be incorporated into the PEA-driven FN fibrillar networks.
3.3. The availability of functional domains and BMP2 absorption
The heparin II domain of FN is less accessible when the molecule is in its globular conformation. However, it is exposed once FN is in the fibrillar network [33]. The availability of heparin II binding domains was measured by ELISA using the antibody P5F3, which recognises the heparin II domain of FN [14,34]. As expected, there was more heparin II exposed on FN and FN + VN coated surfaces compared to VN only (Fig. 3C). There was no significant difference between FN-only networks and the FN + VN networks, indicating that the addition of VN has no positive or negative effect on FN heparin II domain exposure. Only a background signal was observed on PEA + VN, indicating the antibody is specific to the heparin-II domain of FN. Given that there is no commercial antibody specific to the heparin-II domain of VN, the availability of the heparin-II domain of VN was not evaluated. BMP2 is known to bind to FN and VN [3]. To quantify BMP-2 adsorption on the coated substrates, a BMP2 ELISA was performed. Interestingly, compared to FN only, there was a significant increase in BMP2 adsorbed onto the FN + VN surface, suggesting that the FN + VN surface could increase the physiological, solid-state, presentation of BMP2 (Fig. 3D). This may be due to the ability of VN in improving fibril formation [23], thus exposing more GF binding regions. Notably, previous work has demonstrated that 90% of the adsorbed BMP2 remains on the surface of FN networks after 14 days [13], indicating such ECM-GF bonding is stable and thus retains GFs within the ECM network.
3.4. MSC adhesion on ECM-modified substrates
To evaluate MSC adhesion onto different ECM coated substrates, cell morphology and cell adhesion were analyzed. Three hours after seeding, cells were stained for phalloidin and vinculin to analyse initial adhesion responses. In general, all coatings enhanced cell spreading compared to TCP control, with cells on FN and FN + VN surfaces being the most spread (Fig. 4C). However, no significant difference was observed between FN only and FN + VN groups (Fig. 4C; Fig. S5A, Supporting Information). The MSCs on FN and FN + VN surfaces with significantly larger cell areas were also more rounded than those on the TCP control surface (Fig. 4C). Compared to VN alone, MSCs on FN + VN exhibited significantly increased spreading, suggesting that the presence of FN could enhance VN-mediated cell spreading (Fig. 4C). Vinculin is a component of the focal adhesion (FA) complex. It is thought to stabilise talin unfolding, thus connecting the individual integrins with the actin cytoskeleton [35]. Therefore, as it is expressed throughout adhesions, measurement of the length of vinculin patterns correlates to the number of clustered integrins at each FA site. The ECM network surfaces demonstrated that, compared to the TCP control, MSCs developed larger and longer FAs with FN, VN/FN and VN coatings, indicating ECM protein coating enhances FA formation (Fig. 4D and E). Further, MSCs on FN + VN surfaces developed larger (1.687 ± 0.972 μm2) and longer (2.140 ± 0.849 μm) FAs than the cells on FN alone (FA area 1.501 ± 0.809 μm2; FA length 2.029 ± 0.760 μm) or VN alone (FA area 1.472 ± 0.986 μm2; FA length 1.984 ± 0.870 μm) (Fig. 4D and E). While the overall differences were subtle, the data indicates that FN + VN coatings could induce significantly increased cell adhesion, perhaps illustrating the importance of ECM heterogeneity.
Different integrins are known to couple to different ECM proteins. Integrin α5 is known to have high specificity for binding FN, while αV is found to bind to both FN and VN [5,36,37]. Super-resolution microscopy was performed to determine the integrin type in the FAs on each ECM-coated surface. As expected, fibrillar α5 integrins were observed at the end of actin filaments for MSCs on FN and FN + VN surfaces but appeared more diffuse/less fibrillar on VN only surface (Fig. 5, First lane). In terms of αV integrin distribution, most αV integrins were distributed in the perinuclear region rather than at the cell periphery for all conditions (Fig. 5, Second lane).
3.5. Immobilized BMP2 enhances cell adhesion
The synergistic crosstalk between GF receptors and integrin receptors can regulate actin organization, cell adhesion and cell differentiation [4,7]. By functionalizing BMP2 onto FN/FN + VN/VN coated surfaces, the effects of matrix-bound BMP2 and ECM composition on cell adhesion were evaluated based on phalloidin and vinculin staining. Compared to soluble BMP2, immobilized BMP2 promoted MSC spreading and adhesion. MSCs had an increased surface area on all ECM + BMP2 surfaces (Fig. 6C). However, MSCs on FN + BMP2 and FN + VN + BMP2 had significantly increased surface areas than those on VN + BMP2 (Fig. 6C). Interestingly, analysis of FAs revealed that FN + VN + BMP2 surface led to the development of larger (1.620 ± 0.920 μm2) and longer (2.150 ± 0.862 μm) FAs than the ones on the FN + BMP2 (FA area 1.556 ± 0.865 μm2; FA length 2.095 ± 0.828 μm) and VN + BMP2 (FA area 1.247 ± 0.884 μm2; FA length 1.841 ± 0.835 μm) substrates (Fig. 6D and E), even though the differences were subtle. These indicated the addition of GFs such as BMP-2, may further enhance cell adhesion, but only when the GF is presented in solid-state and sequestered by the ECM, rather than as soluble administration.
Given the synergy of GF receptors and integrins, the morphological features of the BMP2 receptor (BMP2R) and integrin αV were characterised by super-resolution microscopy. When BMP2 was presented in solid-state, the BMP2 receptors were observed to take on a fibrillar appearance at the cell edge of MSCs on FN + BMP2 and FN + VN + BMP2 substrates (Fig. 7A and B, Second lane). However, with MSCs seeded on VN + BMP2 substrates and the MSCs treated with soluble BMP2, the BMP2R were mostly distributed in the perinuclear region, and were dot-like in appearance, rather than having an organized fibrillar morphology (Fig. 7C and D, Second lane). As for the αV integrin, there was no significant morphology difference in αV integrin on the different ECM surfaces (Fig. 7, First lane).
3.6. FN + VN BMP2 surface enhances MSC osteogenesis
Given that FN + VN surfaces adsorbed increased BMP2 (Fig. 3D), promoted cell adhesion (Fig. 6) and drove BMP2R as a fibrillar appearance (Fig. 7), we hypothesised that these substrates could enhance the osteogenic differentiation of MSCs. With this hypothesis, MSCs were cultured on ECM-coated surfaces for 28 days, and the expressions of osteoblastic markers osteopontin (OPN) and osteocalcin (OCN) were evaluated. During the culture, most MSCs on the VN + BMP2 surface detached from the substrates at day ∼14, thus this condition was excluded from the analysis. MSCs grown in the osteogenic medium were used as a positive control, these expressed OPN and OCN, as well as supporting matrix mineralization, confirming the osteogenic potential of the cells (Figs. S6 and S7, Supporting Information). As expected, FN + VN + BMP2 substrates led to increased expression of OPN and OCN, when compared to FN + BMP2 substrates (Fig. 8A, 7D and 8B, 7E). Further to this, matrix mineralization was confirmed by von Kossa staining. MSCs cultured on FN + VN BMP2 surfaces showed a significantly higher level of mineralization compared to the FN + BMP2 surface (Fig. 8C and F). Taken together, the FN + VN + BMP2 surface was able to significantly enhance the osteogenic differentiation of MSCs.
The SMAD signalling pathway is critical in BMP2-mediated MSC osteogenesis. Upon GF binding, SMADs 1, 5 and 9 can be phosphorylated by BMP2R, leading to their translocation to the nuclei to activate the osteogenic Runt-related transcription factor 2 (RUNX2) [38]. Thus, we sought to investigate the SMAD 1/5/9 activation. In-cell western (ICW) was performed to assess SMAD 1/5/9 phosphorylation in MSCs seeded on different substrates. Increased phosphorylated SMAD (pSMAD) was detected within cells on FN + VN + BMP2 when compared to cells on the FN + BMP2 substrates and the ones treated by soluble BMP2 (Fig. 8G). These results suggested that BMP2-SMAD signalling was enhanced in MSCs by culture on the FN + VN + BMP2 surface.
4. Discussion
In this new report, we evaluate the effect of solid-state, ECM-based, presentation of FN and VN on MSC adhesion and MSC osteogenic differentiation. XPS analysis confirmed the successful polymerization of PEA onto TCP substrates (Fig. 2). The chemical signature of PEA polymerised substrates was similar to examples shown in previous work [13,26]. By AFM, VN was observed within the FN fibrillar network on the FN + VN absorbed PEA surface, postulating that VN could be likely incorporated with the PEA-driven FN fibril (Fig. 3A–ii). This physiological-like network structure promoted MSC spreading and adhesion (Figs. 4 and 6; Fig. S5, Supporting Information). Then, BMP2 was adsorbed, leading to solid-state GF presentation to MSCs. Our results indicated that increasing the complexity of the ECM network from FN only to incorporate FN + VN, led to enhanced BMP2-mediated osteogenesis of MSCs. We observed up-regulation of osteoblastic marker expression, OPN and OCN, as well as mineralization deposition (Fig. 8; Figs. S6 and S7, Supporting Information). Moreover, the increased phosphorylation of SMAD 1/5/9 signalling was observed on FN + VN + BMP-2 substrates, which may contribute to the enhanced osteogenesis.
The absorption, conformation and bioactivity of the ECM proteins are dependent on the surface chemical modification and surface hydrophobicity [39]. Via functionalization with different chemical groups (e.g. CH3, NH2, OH), self-assembled monolayers have been utilised to systematically study the absorption and conformation of FN and VN coated onto these surfaces [40,41]. Overall, both FN and VN adsorbed more onto hydrophobic surfaces, for example, functionalized with the CH3 groups [42,43]. VN absorbtion onto such a hydrophobic surface, however, resulted in the hiding of cell adhesion domains [40]. In our present study, the globular conformations of VN were confirmed on the hydrophobic PEA surface as well, theoretically hiding their integrin-binding domains and thus attenuating cell adhesion (Fig. 3, Fig. 4). Interestingly, compared to the VN alone, the addition of FN into the VN coating promoted cell adhesion, indicating that more cell-binding domains were exposed when FN and VN were co-adsorbed on the PEA surface. Thus, we can postulate that incorporation into the FN networks could enhance the exposure of the VN cell-binding domain. Due to the lower molecular weight of VN than FN, FN perhaps absorbs first, and VN absorbs to the PEA surface subsequently. The pre-adsorbed FN layer on a fully covered substrate lowers the hydrophobicity of the surface, perhaps allowing the conformational transition of VN to reveal RGD [40]. Moreover, as VN is known to interact with other ECM proteins via their heparin-binding domains [15,44], the pre-adsorbed FN layer can be postulated to provide further sites for VN interactions. Future studies should be carried out to clarify these hypotheses.
Integrins are generally believed to mediate cell-ECM interaction, subsequently stimulating the intracellular downstream signal pathways after initiating cell adhesion [5]. In our present study, we observed that α5 integrins can form fibrillar clusters in the MSCs adherent to the FN and FN + VN surface (Fig. 5). In contrast, α5 integrins were observed to be dot-like in the MSCs adherent to the VN-only surface, suggesting that the VN is insufficient to induce α5 integrin clustering. These results again highlight that the α5 integrins canonically bind to FN, rather than VN [19,33]. The fibrillar α5 integrins are capable of activating RhoA activity in cells and driving the formation of contractile actin stress fibres [45,46]. Interestingly, in the context of cell area and FA development, we found that the mix of FN and VN on the PEA surface could promote cell adhesion better than FN alone (Fig. 4; Fig. S5, Supporting Information), indicating the important role of heterogeneous ECM composition in improving biomaterial-cell interaction.
Matrix-bound GFs allow for a robust synergy between the integrins and GF receptors [47]. In our present study, compared to the BMP2 in soluble format, BMP2 bound within the matrix can significantly induce cell spreading and FA development. The activated GF receptors within the matrix can act synergistically with integrin-related signals, amplifying both effects [47]. As a result, BMP2 presented in a matrix-bound form can strengthen early cell adhesion events, including adhesion and migration [[48], [49], [50]]. As the αvβ3 activation has been implicated in BMP2-dependent cell adhesion [49], αv integrins were stained and their assembly was analyzed. However, no significant difference in αv integrin appearance was observed among all the groups studied (Fig. 7). It is, therefore, likely that BMP2-induced cell adhesion on the FN + VN surface is αvβ3-independent. Indeed, it has been shown that for surfaces presenting immobilized BMP2, αvβ3 integrin blocking either did not affect cell spreading [48]. It should be noted that the α5β1 integrins are involved in BMP2-mediated cell adhesion as well, and this is deserving of further investigation [48,51].
In our present study, compared to BMP2 delivered in a soluble manner, BMP2 presented in matrix-bound (FN and FN + VN) format significantly activated the BMP2-dependent SMAD signalling pathway (Fig. 8G), in which SMADs 1, 5 and 9 can be phosphorylated and translocated to nuclei to activate osteogenesis-related transcriptional factors, such as RUNX2 [38]. These results emphasized again the concept that the matrix presentation of GFs can result in high efficiency, in terms of activation of biological functions, even at a very low dose [52,53]. Strikingly, our super-resolution images illustrated that matrix-bound BMP2, rather than the soluble BMP2 could induce BMP2 receptors to cluster with a fibrillar appearance (Fig. 7), even though the exact mechanism for this cluster is currently unknown. We speculated that similarly to the integrin clustering, BMP2 receptors can cluster as well. The cytosolic tyrosine kinase focal adhesion kinase (FAK) can bridge the cytoplasmic tails of growth factor receptors and integrins through its amino and carboxyl termini, respectively [54,55]. Once integrins cluster, GF receptors could be spontaneously clustered, leading to the formation of the integrin-growth-factor-receptors complex [47]. Again, further investigation is required to provide definitive evidence for this hypothesis.
It should be noted that although traditional culture methods that supplement various GFs into media have been valuable in our understanding of the effects of GFs on cell behaviours, these methods have disadvantages, such as high cost, supraphysiological dose administration, and off-target effects [4,7]; these disadvantages have been taken into clinic. For example, the high dose of BMP2 (1.5 mg/ml; INFUSE Bone Graft; Medtronic) was approved by the Food and Drug Administration for spinal fusion and the treatment of acute, open tibial shaft fractures [56]. However, in their clinical practice, various adverse events such as surgical site infection and heterotopic bone were reported [[57], [58], [59]]. Thus, new biomaterials require engineering to deliver BMP2 in a bioactive form at a low dose, so as to achieve higher osteogenic efficiency safely [1,51,60]. For example, protein engineering techniques, including the use of peptides that bind heparin and GFs [61], and the use of layer-by-layer technologies [62], are reported to be effective to deliver GFs from material surfaces. However, these approaches do not exploit the robust synergy between the integrins and GF receptors to enhance accelerated regeneration [52].
The PEA system allows for physiological, ultralow doses (ng) of GFs to be tethered within the matrix, leading to more precise and effective presentation to cells, followed by on-target guiding of cell differentiation. As a proof of concept, in our previous and present studies, BMP2, and VEGF, have been adsorbed within the ECM-modified PEA surfaces, with promising outcomes in the field of bone formation and vascularization both in vitro and in vivo [[12], [13], [14]]. Thus, PEA holds great potential for use in the field of tissue engineering, especially where delivery GFs is important to achieve cellular effects.
5. Conclusion
In conclusion, we have shown that PEA surface coatings are an optimal platform for cell-material interaction studies. Further to this, we demonstrate that combining FN and VN into fibrillar networks promotes MSC adhesion, efficiently presents of BMP2 to MSCs, and enhances BMP2-mediated MSC osteogenic differentiation. This work also demonstrates the use of the PEA system to recapitulate ECM ex vivo with controlled degrees of complexity. This is a useful tool for the investigation into cell adhesion dynamics and integrin-GF receptor crosstalk studies. This system may offer insights into therapeutically relevant tissue engineering applications that can be utilised in the clinic. Given that the PEA has already been used in veterinary trials with FN and BMP2, it is easily envisioned that systems with differing ECM compositions and complexities could be utilised for varied applications in the clinic.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
This work was supported by an EPSRC Programme Grant (EP/P001114/1). YB. acknowledges the support from China Scholarship Council (#201908060063). X-ray photoelectron spectroscopy was conducted by the National EPSRC XPS Users' Service (NEXUS), Newcastle.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2022.100367.
Contributor Information
Yinbo Xiao, Email: y.xiao.1@research.gla.ac.uk.
Matthew J. Dalby, Email: Matthew.Dalby@glasgow.ac.uk.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Oliver-Cervelló L., Martin-Gómez H., Reyes L., Noureddine F., Ada Cavalcanti-Adam E., Ginebra M.P., Mas-Moruno C. An engineered biomimetic peptide regulates cell behavior by synergistic integrin and growth factor signaling. Adv. Healthc. Mater. 2021;10 doi: 10.1002/adhm.202001757. [DOI] [PubMed] [Google Scholar]
- 2.Hussey G.S., Dziki J.L., Badylak S.F. Extracellular matrix-based materials for regenerative medicine. Nat. Rev. Mater. 2018;3:159–173. doi: 10.1038/s41578-018-0023-x. [DOI] [Google Scholar]
- 3.Martino M.M., Briquez P.S., Güç E., Tortelli F., Kilarski W.W., Metzger S., Rice J.J., Kuhn G.A., Müller R., Swartz M.A., Hubbell J.A. Matrix enhance tissue healing. Science. 1979;343(2014):885–889. doi: 10.1126/science.1247663. [DOI] [PubMed] [Google Scholar]
- 4.Cipitria A., Salmeron-Sanchez M. Mechanotransduction and growth factor signalling to engineer cellular microenvironments. Adv. Healthc. Mater. 2017;6 doi: 10.1002/adhm.201700052. [DOI] [PubMed] [Google Scholar]
- 5.Kechagia J.Z., Ivaska J., Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat. Rev. Mol. Cell Biol. 2019;20:457–473. doi: 10.1038/s41580-019-0134-2. [DOI] [PubMed] [Google Scholar]
- 6.Hynes R.O. The extracellular matrix: not just pretty fibrils. Science. 1979;326:1216–1219. doi: 10.1126/science.1176009. 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dalby M.J., García A.J., Salmeron-Sanchez M. Receptor control in mesenchymal stem cell engineering. Nat. Rev. Mater. 2018;3 doi: 10.1038/natrevmats.2017.91. [DOI] [Google Scholar]
- 8.Mecham R.P. 2011. Cell Biology of Extracellular Matrix. [DOI] [Google Scholar]
- 9.Donnelly H., Salmeron-Sanchez M., Dalby M.J. Designing stem cell niches for differentiation and self-renewal. J. R. Soc. Interface. 2018;15:20180318–20180388. doi: 10.1098/rsif.2018.0388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gugutkov D., Altankov G., Rodríguez Hernández J.C., Monleón Pradas M., Salmerón Sánchez M. Fibronectin activity on substrates with controlled - OH density. J. Biomed. Mater. Res. - Part A. 2010;92:322–331. doi: 10.1002/jbm.a.32374. [DOI] [PubMed] [Google Scholar]
- 11.Salmerón-Sánchez M., Rico P., Moratal D., Lee T.T., Schwarzbauer J.E., García A.J. Role of material-driven fibronectin fibrillogenesis in cell differentiation. Biomaterials. 2011;32:2099–2105. doi: 10.1016/j.biomaterials.2010.11.057. [DOI] [PubMed] [Google Scholar]
- 12.Moulisová V., Gonzalez-García C., Cantini M., Rodrigo-Navarro A., Weaver J., Costell M., Sabater i Serra R., Dalby M.J., García A.J., Salmerón-Sánchez M. Engineered microenvironments for synergistic VEGF – integrin signalling during vascularization. Biomaterials. 2017;126:61–74. doi: 10.1016/j.biomaterials.2017.02.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cheng Z.A., Alba-Perez A., Gonzalez-Garcia C., Donnelly H., Llopis-Hernandez V., Jayawarna V., Childs P., Shields D.W., Cantini M., Ruiz-Cantu L., Reid A., Windmill J.F.C., Addison E.S., Corr S., Marshall W.G., Dalby M.J., Salmeron-Sanchez M. Nanoscale coatings for ultralow dose BMP-2-driven regeneration of critical-sized bone defects. Adv. Sci. 2019;6 doi: 10.1002/advs.201800361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Llopis-Hernández V., Cantini M., González-García C., Cheng Z.A., Yang J., Tsimbouri P.M., García A.J., Dalby M.J., Salmerón-Sánchez M. Material-driven fibronectin assembly for high-efficiency presentation of growth factors. Sci. Adv. 2016;2 doi: 10.1126/sciadv.1600188. e1600188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Leavesley D.I., Kashyap A.S., Croll T., Sivaramakrishnan M., Shokoohmand A., Hollier B.G., Upton Z. Vitronectin - master controller or micromanager? IUBMB Life. 2013;65:807–818. doi: 10.1002/iub.1203. [DOI] [PubMed] [Google Scholar]
- 16.Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. JCB (J. Cell Biol.) 1995;130:503–506. doi: 10.1083/jcb.130.3.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Toromanov G., Gugutkov D., Gustavsson J., Planell J., Salmerón-Sánchez M., Altankov G. Dynamic behavior of vitronectin at the cell-material interface. ACS Biomater. Sci. Eng. 2015;1:927–934. doi: 10.1021/acsbiomaterials.5b00147. [DOI] [PubMed] [Google Scholar]
- 18.Moser T.L., Enghild J.J., Pizzo S.V., Stack M.S. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem. J. 1995;307:867–873. doi: 10.1042/bj3070867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Felding-Habermann B., Cheresh D.A. Vitronectin and its receptors. Curr. Opin. Cell Biol. 1993;5:864–868. doi: 10.1016/0955-0674(93)90036-p. https://www.ncbi.nlm.nih.gov/pubmed/?term=Felding-Habermann+and+Cheresh%2C+1993 [DOI] [PubMed] [Google Scholar]
- 20.Su Y.C., Riesbeck K. second ed. Elsevier; 2018. Vitronectin. [DOI] [Google Scholar]
- 21.Roca-Cusachs P., Gauthier N.C., Del Rio A., Sheetz M.P. Clustering of α5β1 integrins determines adhesion strength whereas αvβ3 and talin enable mechanotransduction. Proc. Natl. Acad. Sci. U. S. A. 2009;106:16245–16250. doi: 10.1073/pnas.0902818106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pankov R., Cukierman E., Katz B.Z., Matsumoto K., Lin D.C., Lin S., Hahn C., Yamada K.M. Integrin dynamics and matrix assembly: tensin-dependent translocation of α5β1 integrins promotes early fibronectin fibrillogenesis. JCB (J. Cell Biol.) 2000;148:1075–1090. doi: 10.1083/jcb.148.5.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cantini M., Gomide K., Moulisova V., González-García C., Salmerón-Sánchez M. Vitronectin as a micromanager of cell response in material-driven fibronectin nanonetworks. Adv. Biosyst. 2017;1 doi: 10.1002/adbi.201700047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.González-García C., Cantini M., Moratal D., Altankov G., Salmerón-Sánchez M. Vitronectin alters fibronectin organization at the cell-material interface. Colloids Surf. B Biointerfaces. 2013;111:618–625. doi: 10.1016/j.colsurfb.2013.07.016. [DOI] [PubMed] [Google Scholar]
- 25.Toromanov G., González-García C., Altankov G., Salmerón-Sánchez M. Vitronectin activity on polymer substrates with controlled -OH density. Polymer. 2010;51:2329–2336. doi: 10.1016/j.polymer.2010.03.041. [DOI] [Google Scholar]
- 26.Alba-Perez A., Jayawarna V., Childs P.G., Dalby M.J., Salmeron-Sanchez M. Plasma polymerised nanoscale coatings of controlled thickness for efficient solid-phase presentation of growth factors. Mater. Sci. Eng. C. 2020;113 doi: 10.1016/j.msec.2020.110966. [DOI] [PubMed] [Google Scholar]
- 27.Dumic-Cule I., Peric M., Kucko L., Grgurevic L., Pecina M., Vukicevic S. Bone morphogenetic proteins in fracture repair. Int. Orthop. 2018;42:2619–2626. doi: 10.1007/s00264-018-4153-y. [DOI] [PubMed] [Google Scholar]
- 28.Gupta M.C., Khan S.N. Application of bone morphogenetic proteins in spinal fusion. Cytokine Growth Factor Rev. 2005;16:347–355. doi: 10.1016/j.cytogfr.2005.02.004. [DOI] [PubMed] [Google Scholar]
- 29.Horzum U., Ozdil B., Pesen-Okvur D. Step-by-step quantitative analysis of focal adhesions. MethodsX. 2014;1:56–59. doi: 10.1016/j.mex.2014.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pireaux J.J. High resolution XPS of organic polymers: the Scienta ESCA300 database. J. Electron. Spectrosc. Relat. Phenom. 1993;62:371–372. doi: 10.1016/0368-2048(93)85006-7. [DOI] [Google Scholar]
- 31.Sprott M.R., Gallego-Ferrer G., Dalby M.J., Salmerón-Sánchez M., Cantini M. Functionalization of PLLA with polymer brushes to trigger the assembly of fibronectin into nanonetworks. Adv. Healthc. Mater. 2019;8 doi: 10.1002/adhm.201801469. [DOI] [PubMed] [Google Scholar]
- 32.Harrington R.E., Guda T., Lambert B., Martin J. Sterilization and disinfection of biomaterials for medical devices. Biomater. Sci. 2020 doi: 10.1016/b978-0-12-816137-1.00091-x. [DOI] [Google Scholar]
- 33.Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002;115:3861–3863. doi: 10.1242/jcs.00059. [DOI] [PubMed] [Google Scholar]
- 34.Martino M.M., Hubbell J.A. The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. Faseb. J. 2010;24:4711–4721. doi: 10.1096/fj.09-151282. [DOI] [PubMed] [Google Scholar]
- 35.Kanchanawong P., Shtengel G., Pasapera A.M., Ramko E.B., Davidson M.W., Hess H.F., Waterman C.M. Nanoscale architecture of integrin-based cell adhesions. Nature. 2010;468:580–584. doi: 10.1038/nature09621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296:151–155. doi: 10.1126/science.1069040. 1979. [DOI] [PubMed] [Google Scholar]
- 37.Takagi J., Strokovich K., Springer T.A., Walz T. Structure of integrin α5β1 in complex with fibronectin. EMBO J. 2003;22:4607–4615. doi: 10.1093/emboj/cdg445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Phimphilai M., Zhao Z., Boules H., Roca H., Franceschi R.T. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone Miner. Res. 2006;21:637–646. doi: 10.1359/jbmr.060109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chen L., Yan C., Zheng Z. Functional polymer surfaces for controlling cell behaviors. Mater. Today. 2018;21:38–59. doi: 10.1016/j.mattod.2017.07.002. [DOI] [Google Scholar]
- 40.Li T., Hao L., Li J., Du C., Wang Y. Insight into vitronectin structural evolution on material surface chemistries: the mediation for cell adhesion. Bioact. Mater. 2020;5:1044–1052. doi: 10.1016/j.bioactmat.2020.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lin M., Wang H., Ruan C., Xing J., Wang J., Li Y., Wang Y., Luo Y. Adsorption force of fibronectin on various surface chemistries and its vital role in osteoblast adhesion. Biomacromolecules. 2015;16:973–984. doi: 10.1021/bm501873g. [DOI] [PubMed] [Google Scholar]
- 42.Barrias C.C., Martins M.C.L., Almeida-Porada G., Barbosa M.A., Granja P.L. The correlation between the adsorption of adhesive proteins and cell behaviour on hydroxyl-methyl mixed self-assembled monolayers. Biomaterials. 2009;30 doi: 10.1016/j.biomaterials.2008.09.048. [DOI] [PubMed] [Google Scholar]
- 43.Keselowsky B.G., Collard D.M., García A.J. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J. Biomed. Mater. Res. - Part A. 2003;66:247–259. doi: 10.1002/jbm.a.10537. [DOI] [PubMed] [Google Scholar]
- 44.The Extracellular Matrix: an Overview. 2011. [DOI] [Google Scholar]
- 45.Danen E.H.J., Sonneveld P., Brakebusch C., Fässler R., Sonnenberg A. The fibronectin-binding integrins α5β1 and αvβ3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. JCB (J. Cell Biol.) 2002;159:1071–1086. doi: 10.1083/jcb.200205014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Morgan M.R., Byron A., Humphries M.J., Bass M.D. Giving off mixed signals - distinct functions of α5β 1 and αvβ3 integrins in regulating cell behaviour. IUBMB Life. 2009;61 doi: 10.1002/iub.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Comoglio P.M., Boccaccio C., Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr. Opin. Cell Biol. 2003;15 doi: 10.1016/S0955-0674(03)00096-6. [DOI] [PubMed] [Google Scholar]
- 48.Posa F., Baha-Schwab E.H., Wei Q., di Benedetto A., Neubauer S., Reichart F., Kessler H., Spatz J.P., Albigez-Rizo C., Mori G., Cavalcanti-Adam E.A. Surface Co-presentation of BMP-2 and integrin selective ligands at the nanoscale favors α5β1 integrin-mediated adhesion. Biomaterials. 2021;267 doi: 10.1016/j.biomaterials.2020.120484. [DOI] [PubMed] [Google Scholar]
- 49.Fourel L., Valat A., Faurobert E., Guillot R., Bourrin-Reynard I., Ren K., Lafanechère L., Planus E., Picart C., Albiges-Rizo C. β3 integrin-mediated spreading induced by matrix-bound BMP-2 controls Smad signaling in a stiffness-independent manner. JCB (J. Cell Biol.) 2016;212:693–706. doi: 10.1083/jcb.201508018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Gamell C., Osses N., Bartrons R., Rückle T., Camps M., Rosa J.L., Ventura F. BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J. Cell Sci. 2008;121:3960–3970. doi: 10.1242/jcs.031286. [DOI] [PubMed] [Google Scholar]
- 51.Martino M.M., Tortelli F., Mochizuki M., Traub S., Ben-David D., Kuhn G.A., Müller R., Livne E., Eming S.A., Hubbell J.A. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 2011;3 doi: 10.1126/scitranslmed.3002614. [DOI] [PubMed] [Google Scholar]
- 52.Martino M.M., Briquez P.S., Maruyama K., Hubbell J.A. Extracellular matrix-inspired growth factor delivery systems for bone regeneration. Adv. Drug Deliv. Rev. 2015;94 doi: 10.1016/j.addr.2015.04.007. [DOI] [PubMed] [Google Scholar]
- 53.Mitchell A.C., Briquez P.S., Hubbell J.A., Cochran J.R. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016;30 doi: 10.1016/j.actbio.2015.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., Schlaepfer D.D. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2000;2 doi: 10.1038/35010517. [DOI] [PubMed] [Google Scholar]
- 55.Ivankovic-Dikic I., Grönroos E., Blaukat A., Barth B.U., Dikic I. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins. Nat. Cell Biol. 2000;2 doi: 10.1038/35023515. [DOI] [PubMed] [Google Scholar]
- 56.Garrison K.R., Donell S., Ryder J., Shemilt I., Mugford M., Harvey I., Song F. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol. Assess. 2007;11 doi: 10.3310/hta11300. [DOI] [PubMed] [Google Scholar]
- 57.Woo E.J. Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J. Oral Maxillofac. Surg. 2012;70:765–767. doi: 10.1016/j.joms.2011.09.008. [DOI] [PubMed] [Google Scholar]
- 58.Woo E.J. Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures general. Clin. Orthop. Relat. Res. 2013;471:1707–1711. doi: 10.1007/s11999-012-2684-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Woo E.J. Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database. Spine J. 2012;12:894–899. doi: 10.1016/j.spinee.2012.09.052. [DOI] [PubMed] [Google Scholar]
- 60.Kisiel M., Martino M.M., Ventura M., Hubbell J.A., Hilborn J., Ossipov D.A. Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment. Biomaterials. 2013;34 doi: 10.1016/j.biomaterials.2012.10.015. [DOI] [PubMed] [Google Scholar]
- 61.Hudalla G.A., Kouris N.A., Koepsel J.T., Ogle B.M., Murphy W.L. Harnessing endogenous growth factor activity modulates stem cell behavior. Integr. Biol. 2011;3 doi: 10.1039/c1ib00021g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Crouzier T., Fourel L., Boudou T., Albigès-Rizo C., Picart C., Crouzier T., Fourel L., Boudou T., Picart C., Albigès-Rizo C. Presentation of BMP-2 from a soft biopolymeric film unveils its activity on cell adhesion and migration. Adv. Mater. 2011;23:111–118. doi: 10.1002/adma.201004637. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.